We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




RF Ablation Effective in Treating Lung Cancer

By HospiMedica staff writers
Posted on 23 Dec 2002
The results of a clinical study have confirmed that radiofrequency (RF) ablation appears to be effective in treating cancerous lung tumors in patients who are not surgical candidates.

The study involved 62 patients with primary lung cancer or lung metastases who were not surgical candidates. More...
The patients were treated with the RF ablation system of Rita Medical Systems, Inc. (Mountain View, CA, USA). This system allows doctors to deliver monitored and controlled levels of RF energy into the cancerous tissue through an array of thin electrodes, which heat and destroy the targeted tissue. In many cases, this minimally invasive procedure can be performed using only a local anesthetic and intravenous sedation.

Following treatment, the patients' progress was assessed over a one-year period using computed tomography (CT) imaging. For 25 patients in the study who were followed for at least six months, 93% of tumors had stabilized or decreased in size. Over this period, these tumors would typically be expected to at least double in size, says Rita Medical. No major complications were reported.

"These results are very impressive. The data presented here clearly show that Rita can offer a new approach in the treatment of lung cancer for the majority of patients who cannot have surgery,” said Riccardo Lencioni, M.D., professor of diagnostic and interventional radiology at the University of Pisa (Italy), who presented the study results at the annual meeting of the Radiological Society of North America (RSNA) in Chicago, IL (USA).




Related Links:
Rita Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.